As part of Mitsubishi Tanabe Pharma America’s (MTPA) mission to improve health and well-being of those living with ALS, the company may provide financial support for independent third-party organizations. We hope the following helps provide guidance to decide whether it is appropriate to seek support and, if so, how to go about it.
MTPA seeks to support organizations and programs that help people living with ALS and those who care for them, and for this reason the company has a strong preference for programs that directly support patient education and care. All requests for funding should clearly align with these things; we may not provide general support for operations.
Sponsorship requests must clearly identify the tangible benefit offered to Mitsubishi Tanabe Pharma America and the value of the tangible benefit must be reasonable and generally consistent with norms for comparable events or benefits. The sponsorship opportunity must be genuinely available to other potential sponsors.
Sponsorships whose sole purpose is to fund an organization’s general operating costs, routine business expenses, or capital costs (infrastructure), or political or lobbying activities are not eligible for sponsorship funding.
Sponsorship requests must include:
- Request Letter on the Organization's Letterhead - The request letter should 1) be on the organization's letterhead, 2) include a description of the overall program or event, 3) contain a summary description of the levels of sponsorship available and the tangible benefits to Mitsubishi Tanabe Pharma America of each level.
- IRS Letter of Determination/501c3 (if applicable)
- Sponsorship Levels Available - These may be provided in a separate document or covered in the request letter but must give a detailed list of sponsorship options available and the tangible benefits to Mitsubishi Tanabe Pharma America of each level.
- W9 or W8 - A current copy of your organization's signed and dated (not more than 2 years old) W9 or W8 is required
Sponsorship requests will be reviewed on a rolling basis. Requests must be submitted 60 days in advance of when a funding decision is needed by the organization.
In all cases, we notify organizations by email. If a request is approved, we will send a letter of agreement via FedEx, which should be signed and returned in the prepaid FedEx envelope provided. Funds will then be disbursed as quickly as possible.
Should you have any questions you may contact the Mitsubishi Tanabe Pharma America team via email, but please note that requests must be submitted through the Portal; requests sent by email will not be reviewed:
For Technical Support, please contact SteepRock Client Services:
Phone: +1 718-576-1406 (M-F 8am – 6pm US ET)